InvestorsHub Logo
Followers 483
Posts 61598
Boards Moderated 14
Alias Born 09/20/2001

Re: None

Saturday, 08/11/2018 12:37:29 AM

Saturday, August 11, 2018 12:37:29 AM

Post# of 1889
Good AMPE article on Seeking Alpha -

Very clear explanation of what is going on. Here is the conclusion:


Investment Summary

The shorts are in control of this stock. They had a field day with me being a paid promoter which I am not. I got hit bad just like all the rest of the longs. I do very detailed research but I CANT FIX STUPID. The latest FDA review panel was clearly out of touch (AKA STUPID). In the AM expect to see multiple Shareholder Class action lawsuits designed to drive the price down. Will they have merit? Of course not but the bottom line is it’s going lower. This is going to be a flushing even and then there is going to be a point in time where bargain shoppers come in and realize wait this wasn’t great news and they do have an uphill battle but ask is their chance of success really this low? The math on this stock is easy when you assume 100 mil shares fully diluted. A $.50 stock price means $50 million. A $1.00 stock means $100 million.
In after hours trading, the stock is about a $100 million valuation but how low can it go? They key to playing this flush is volume when it reaches panic levels. At a certain price shorts will cover because they know this is short lived and it’s not time to throw in the towel just yet. AMPE still has 4 pathways to approval and only 1 results in significant dilution. CEO Macaluso gave a hint that it took them one week to resolve a major issue and they only have a few left to work out. In a couple of weeks this FDA director could come back and rule favorably it’s just too early to throw in the towel. The question is where to add if you are long. I have estimated peak sales at $5 billion which is a $50/share stock. A recent twitter poll projected $30+ price target if the company gets bought out. What has changed? The review committee of the FDA is being difficult but a higher level director is trying to take it by the hand and walk it through the review process. On this announcement are there any investors who think Ampion doesn’t work? If you raise your hand please sell your shares. Ampion works and will eventually be approved the question is will the FDA bureaucracy wipe out all the shareholder equity or can this team of consultants pull some strings and get this back on track?




https://seekingalpha.com/instablog/19785151-michael-sheikh/5197446-ampion-bla-story-drags-don-t-throw-towel-yet




In Peace, In War